CNBC Top Stories

American follows Delta in sealing a labor deal with its pilots this year.

Chinese tech company Baidu reported better-than-expected revenue, up by 15% year-on-year in the second quarter.

Here are some of the tickers on my radar for Tuesday, Aug. 22 taken directly from my reporter's notebook.

Meta's Twitter clone called Threads is now available on the web for people to access via their desktop computers.

Cryptocurrency exchange Coinbase is taking a stake in Circle, the issuer of the USDC stablecoin.

The purchase is on the smaller side because we are hesitant to put too much money to work in a volatile market.

Leaders from five developing nations accounting for nearly half the world's population are gathering in Johannesburg on Tuesday for the 15th BRICS Summit.

Wall Street is set to open higher after the Nasdaq had its best day in the rough month of August.

Thailand has been administered by a caretaker government since March, with its parliament in deadlock.

One analyst is of the view that only nuclear power can deliver cost effective, reliable, and clean energy, solving the problem of reliability

As working age populations decline, Krishna said AI presents one of the only solutions to addressing potential productivity shortfalls.

A confluence of factors is stoking fears that shortage of rice supplies could mark a return to a broad increase in the prices of other food commodities in Asia.

India has slapped a 40% export tax on onions on the back of higher domestic prices of the vegetable.

The president's initial response to the devastating wildfires drew criticism from Republicans, who argued that he should have spoken about it more often.

CNBC's Jim Cramer on Monday encouraged investors to stick with their convictions, especially amid market turbulence.

The bond filing came days before the deadline for Trump and his 18 co-defendants to surrender in Georgia.

Arm is aiming to sell shares to the public during a historically slow period for U.S. tech IPOs.

While the consumer part of Zoom doesn't look as strong as it once did, the enterprise side looks robust enough for executives to raise their forecast.

It's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product. 

Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.